Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
May guide mechanism-informed SVT management; extends prior reviews but leaves open prospective outcome validation.
While the principles of drug management of supraventricular tachyarrhythmias have remained essentially unchanged, such treatment remains empirical in many patients. Recent advances in the understanding of electrophysiological mechanisms have not only rationalised treatment but dictated newer approaches to these and other arrhythmias.
No takes yet. Share an insight, caveat, or question.
Andrew M. Tonkin (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: